THX Pharma
ALTHX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €2 | €0 | €0 | €0 |
| % Growth | 670.5% | -28.6% | 68,819.9% | – |
| Cost of Goods Sold | €3 | €5 | €0 | €9 |
| Gross Profit | -€0 | -€5 | €0 | -€9 |
| % Margin | -14.6% | -1,565.4% | 20% | -1,465,443.5% |
| R&D Expenses | €3 | €8 | €4 | €6 |
| G&A Expenses | €2 | €3 | €7 | €1 |
| SG&A Expenses | €2 | €3 | €2 | €1 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€3 | -€7 | €0 | -€6 |
| Operating Expenses | €2 | €3 | €6 | €1 |
| Operating Income | -€5 | -€8 | -€6 | -€10 |
| % Margin | -210.7% | -2,579.4% | -1,508.1% | -1,580,201% |
| Other Income/Exp. Net | €2 | €0 | -€1 | -€0 |
| Pre-Tax Income | -€3 | -€8 | -€7 | -€10 |
| Tax Expense | €1 | -€1 | -€1 | -€2 |
| Net Income | -€2 | -€7 | -€7 | -€8 |
| % Margin | -77.3% | -2,304.2% | -1,582.8% | -1,353,889.4% |
| EPS | -0.21 | -0.88 | -1.24 | -1.66 |
| % Growth | 76.1% | 29% | 25.3% | – |
| EPS Diluted | -0.21 | -0.88 | -1.23 | -1.66 |
| Weighted Avg Shares Out | 9 | 8 | 5 | 5 |
| Weighted Avg Shares Out Dil | 9 | 8 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €1 |
| EBITDA | -€3 | -€7 | -€6 | -€9 |
| % Margin | -110.8% | -2,492.9% | -1,428.1% | -1,440,519.1% |